MedTrace Logo

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

NCT04969419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75771

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

This study examines melanoma and nonmelanoma skin cancer in people diagnosed with vitiligo compared to matched controls.

Conditions

Interventions

OTHER

Exposure of skin cancer of interest

Melanoma and nonmelanoma skin cancers: squamous cell carcinoma, basal cell carcinoma and actinic keratoses.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Momentum Data

    lead INDUSTRY

Principal Investigators

  • Andrew McGovern, MD · Momentum Data Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-18
Primary Completion
2022-03-31
Completion
2023-04-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969419 on ClinicalTrials.gov